<i>NAT2</i> Slow Acetylator Phenotype as a Significant Risk Factor for Hepatotoxicity Caused by Antituberculosis Drugs: Results From a Multiethnic Nested Case-Control Study
NAT2 Slow Acetylator Phenotype as a Significant Risk Factor for Hepatotoxicity Caused by Antituberculosis Drugs: Results From a Multiethnic Nested Case-Control Study
Spinello Antinori, Emilio Clementi, Carla Carnovale, Cristina Montrasio et al.
Citations
4 citations
Journal
Clinical Infectious Diseases
Topics
Drug-Induced Hepatotoxicity and Protection
Field-Weighted Citation Impact (FWCI)
1.87
article
NAT2 Slow Acetylator Phenotype as a Significant Risk Factor for Hepatotoxicity Caused by Antituberculosis Drugs: Results From a Multiethnic Nested Case-Control Study
Spinello Antinori, Emilio Clementi, Carla Carnovale, Cristina Montrasio, Marco Schiuma, Sonia Radice, Stefania Cheli, Alessandro Torre, Isadora de Oliveira Mariani, Vera Battini, Andrea Gori, Giulia Mosini, Miriam Galimberti, Aurora Civati
article en
4 citations
Abstract
No abstract available for this paper.
Publication Tag
Clinical Infectious DiseasesVol. 81(1)
Institutions
University of Milan (IT), Luigi Sacco Hospital (IT), Ospedale dei Bambini Vittore Buzzi (IT), IRCCS Eugenio Medea (IT), ASST Fatebenefratelli Sacco (IT)